| |
| Device | SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System (Monorail®), SYNERGY™ SHIELD Everolimus-Eluting Plat |
| Generic Name | Coronary drug-eluting stent |
| Applicant | Boston Scientific Corporation One Scimed Pl. Maple Grove, MN 55311 |
| PMA Number | P150003 |
| Supplement Number | S093 |
| Date Received | 03/14/2023 |
| Decision Date | 06/12/2023 |
| Product Code |
NIQ |
| Advisory Committee |
Cardiovascular |
| Supplement Type | Real-Time Process |
| Supplement Reason | Change Design/Components/Specifications/Material |
| Expedited Review Granted? | No |
| Combination Product | Yes |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for changes to the labeling, device packaging, and addition of the 48 mm device delivery system to allow for alignment of the product matrix to include the 48-mm stent size. |